These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice. Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310 [TBL] [Abstract][Full Text] [Related]
45. Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose. Zhang M; Dong C; Xiong S Front Cell Infect Microbiol; 2017; 7():34. PubMed ID: 28224119 [TBL] [Abstract][Full Text] [Related]
46. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. Verreck FA; Vervenne RA; Kondova I; van Kralingen KW; Remarque EJ; Braskamp G; van der Werff NM; Kersbergen A; Ottenhoff TH; Heidt PJ; Gilbert SC; Gicquel B; Hill AV; Martin C; McShane H; Thomas AW PLoS One; 2009; 4(4):e5264. PubMed ID: 19367339 [TBL] [Abstract][Full Text] [Related]
47. Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice. Chuang YM; Pinn ML; Karakousis PC; Hung CF Front Cell Infect Microbiol; 2018; 8():31. PubMed ID: 29473022 [No Abstract] [Full Text] [Related]
48. The Mishra A; Khan A; Singh VK; Glyde E; Saikolappan S; Garnica O; Das K; Veerapandian R; Dhandayuthapani S; Jagannath C Front Immunol; 2024; 15():1321657. PubMed ID: 38975346 [TBL] [Abstract][Full Text] [Related]
49. Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining. Smith SG; Lalor MK; Gorak-Stolinska P; Blitz R; Beveridge NE; Worth A; McShane H; Dockrell HM BMC Immunol; 2010 Jul; 11():35. PubMed ID: 20609237 [TBL] [Abstract][Full Text] [Related]
50. A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis. da Costa AC; Costa-Júnior Ade O; de Oliveira FM; Nogueira SV; Rosa JD; Resende DP; Kipnis A; Junqueira-Kipnis AP PLoS One; 2014; 9(11):e112848. PubMed ID: 25398087 [TBL] [Abstract][Full Text] [Related]
51. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity. Rai PK; Chodisetti SB; Zeng W; Nadeem S; Maurya SK; Pahari S; Janmeja AK; Jackson DC; Agrewala JN J Transl Med; 2017 Oct; 15(1):201. PubMed ID: 28985739 [TBL] [Abstract][Full Text] [Related]
52. Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice. Britton G; MacDonald DC; Brown JS; Collins MK; Goodman AL Immunology; 2015 Oct; 146(2):264-70. PubMed ID: 26095282 [TBL] [Abstract][Full Text] [Related]
53. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy. Lu M; Xia ZY; Bao L Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251 [TBL] [Abstract][Full Text] [Related]
54. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein. Deng YH; He HY; Zhang FJ Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772 [TBL] [Abstract][Full Text] [Related]
55. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518 [TBL] [Abstract][Full Text] [Related]
56. A Mycobacterium bovis BCG-naked DNA prime-boost vaccination strategy induced CD4⁺ and CD8⁺ T-cell response against Mycobacterium tuberculosis immunogens. Lu M; Xia ZY; Bao L J Immunol Res; 2014; 2014():395626. PubMed ID: 24741595 [TBL] [Abstract][Full Text] [Related]
58. Heat-Shock Protein gp96 Enhances T Cell Responses and Protective Potential to Bacillus Calmette-Guérin Vaccine. Ding Y; Zheng H; Feng C; Wang B; Liu C; Mi K; Cao H; Meng S Scand J Immunol; 2016 Oct; 84(4):222-8. PubMed ID: 27417661 [TBL] [Abstract][Full Text] [Related]
59. Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Langermans JA; Andersen P; van Soolingen D; Vervenne RA; Frost PA; van der Laan T; van Pinxteren LA; van den Hombergh J; Kroon S; Peekel I; Florquin S; Thomas AW Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11497-502. PubMed ID: 11562492 [TBL] [Abstract][Full Text] [Related]